发明名称 |
PROSTATE CANCER BIOMARKERS |
摘要 |
<p>The present disclosure relates to a method of determining whether a mammalian subject belongs to a first or a second group of subjects, wherein the risk of having a prostate cancer, such as an aggressive prostate cancer, is higher in the first group than in the second group. The method comprises the steps of: a) evaluating an amount of unglycosylated CNDP1 protein in a sample derived from blood, semen or urine from the subject and determining a sample value corresponding to the evaluated amount; b) comparing the sample value with a predetermined reference value; and if the sample value is lower than or equal to the reference value, c1 ) concluding that the subject belongs to the first group; and if the sample value is higher than the reference value, c2) concluding that the subject belongs to the second group. Further, the present disclosure relates to a similar method based on the protein HCRTR1 as well as corresponding uses and means useful when carrying out the methods.</p> |
申请公布号 |
WO2011149402(A2) |
申请公布日期 |
2011.12.01 |
申请号 |
WO2011SE00102 |
申请日期 |
2011.05.27 |
申请人 |
ATLAS ANTIBODIES AB;SCHWENK, JOCHEN;NILSSON, PETER;UHLEN, MATHIAS |
发明人 |
SCHWENK, JOCHEN;NILSSON, PETER;UHLEN, MATHIAS |
分类号 |
G01N33/574;C07K16/40 |
主分类号 |
G01N33/574 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|